NexGel (NASDAQ:NXGL) Director Purchases 4,546 Shares of Company Stock

NexGel, Inc. (NASDAQ:NXGL – Get Free Report) Director Steven Mark Glassman bought 4,546 shares of NexGel stock in a transaction dated Tuesday, November 10th. The stock was acquired at an average cost of $5.50 per share, with a total value of $25,003.00. Following the completion of the acquisition, the director directly owned 12,379 shares of the company’s stock, valued at approximately $68,084.50. The trade was a 58.04% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website.

NexGel Price Performance

Shares of NXGL traded up $0.09 during trading hours on Friday, reaching $3.88. The company had a trading volume of 13,639 shares, compared to its average volume of 41,562. NexGel, Inc. has a 12-month low of $3.00 and a 12-month high of $41.20. The company has a current ratio of 0.43, a quick ratio of 0.27 and a debt-to-equity ratio of 0.68. The company has a market capitalization of $1.90 million, a price-to-earnings ratio of -0.27 and a beta of 0.81. The firm has a 50 day simple moving average of $4.51 and a 200-day simple moving average of $11.31.

NexGel (NASDAQ:NXGL – Get Free Report) last announced its quarterly earnings results on Friday, August 14th. The company reported ($8.00) EPS for the quarter, missing the consensus estimate of ($2.40) by ($5.60). The firm had revenue of $3.69 million for the quarter, compared to analysts’ expectations of $4.32 million. NexGel had a negative return on equity of 121.18% and a negative net margin of 51.26%. Research analysts expect that NexGel, Inc. will post -18.80 earnings per share for the current year.

Institutional Trading of NexGel

A hedge fund recently bought a new stake in NexGel stock. Empery Asset Management LP bought a new stake in NexGel, Inc. (NASDAQ:NXGL – Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 90,000 shares of the company’s stock, valued at approximately $3,474,000. Empery Asset Management LP owned about 0.98% of NexGel at the end of the most recent quarter. 2.21% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several analysts have weighed in on NXGL shares. Zacks Research raised NexGel to a “hold” rating in a report on Friday, October 2nd. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of NexGel in a research note on Friday, October 9th. Finally, Maxim Group lowered shares of NexGel from a “buy” rating to a “hold” rating in a research report on Monday, August 24th. Two investment analysts have rated the stock with a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Reduce” and a consensus target price of $40.00.

Read Our Latest Analysis on NXGL

About NexGel

(Get Free Report)

NexGel, Inc. (NASDAQ:NXGL) develops and manufactures high-water-content hydrogel products for medical, consumer and other specialized applications. The company uses proprietary formulations and electron-beam processing to produce flexible, skin-compatible products designed to retain moisture and provide cooling, cushioning or conductive properties. Its product applications include wound care, burn and surgical care, pain management, medical diagnostics and personal wellness. NexGel supplies hydrogel sheets, patches and related components used in products such as wound dressings, therapeutic pads and medical electrodes.

Featured Stories

Insider Buying and Selling by Quarter for NexGel (NASDAQ:NXGL)

Receive News & Ratings for NexGel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NexGel and related companies with MarketBeat.com's FREE daily email newsletter.